Search Results - "Mercier, Cedric"

Making time perception shorter with pitch and interval patterns by Sunthorn, Wanchanok, Le Mercier, Cedric, Silpasuwanchai, Chaklam

“…The average attention span of humans is decreasing. To adapt to the change, researchers investigate visual and auditory techniques that alter the perception of…”
Get full text

Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults by Padovani, Laetitia, M.D, Sunyach, Marie-Pierre, M.D, Perol, David, M.D, Mercier, Cedric, M.D., Ph.D, Alapetite, Claire, M.D, Haie-Meder, Christine, M.D, Hoffstetter, Sylvette, M.D, Muracciole, Xavier, M.D, Kerr, Christine, M.D, Wagner, Jean-Philippe, M.D, Lagrange, Jean-Léon, M.D, Maire, Jean-Philippe, M.D, Cowen, Didier, M.D. Ph.D, Frappaz, Didier, M.D, Carrie, Christian, M.D

“…Purpose: To assess prognostic factors for adults with medulloblastoma in a multicenter, retrospective study. Methods and Materials: Data were collected by file…”
Get full text

Optimize administration protocol of capecitabine plus docetaxel combination in metastatic breast cancer patients by Frances, Nicolas, Woloch, Christian, Marouani, Hafedh, Mercier, Cedric, Iliadis, Athanassios

“…Combining several cytotoxics is the current mainstay for treating breast cancer patients. The combination between capecitabine and docetaxel was found to be…”
Get more information

Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile by Mercier, Cedric, Dupuis, Charlotte, Blesius, Aurore, Fanciullino, Raphaelle, Yang, Chen Guang, Padovani, Laetitia, Giacometti, Sarah, Frances, Nicolas, Iliadis, Athanassios, Duffaud, Florence, Ciccolini, Joseph

“…We report here the case of a 19-year-old female patient who suffered from extremely severe toxicities (G4 mucitis, fever, diarrhea, alteration of general…”
Get full text

Integrating pharmacogenetics into gemcitabine dosing-time for a change? by Dahan, Laetitia, André, Nicolas, Mercier, Cédric, Ciccolini, Joseph

“…A number of biomarkers that predict clinical outcome in response to gemcitabine treatment have been identified. These markers could be used in the clinic to…”
Get full text

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy by Berton, Guillaume, Arcani, Robin, Tichadou, Antoine, Farnault, Laure, Roche, Pauline, Colle, Julien, Ivanov, Vadim, Mercier, Cédric, Couderc, Anne-Laure, Costello, Regis, Taïeb, David, Venton, Geoffroy

Get full text

Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies by CICCOLINI, Joseph, DAHAN, Laetitia, ORTIZ, Adrien, FRANCES, Nicolas, ILIADIS, Athanassios, DUFFAUD, Florence, SEITZ, Jean-François, MERCIER, Cédric, ANDRE, Nicolas, EVRARD, Alexandre, DULUC, Muriel, BLESIUS, Aurore, CHENGUANG YANG, GIACOMETTI, Sarah, BRUNET, Caroline, RAYNAL, Caroline

“…PURPOSE Anticipating toxicities with gemcitabine is an ongoing story, and deregulation in cytidine deaminase (CDA) could be associated with increased risk of…”
Get full text

Physicochemical properties and cellular toxicity of (poly)aminoalkoxysilanes-functionalized ZnO quantum dots by Aboulaich, Abdelhay, Tilmaciu, Carmen-Mihaela, Merlin, Christophe, Mercier, Cédric, Guilloteau, Hélène, Medjahdi, Ghouti, Schneider, Raphaël

“…Luminescent ZnO nanocrystals were synthesized by basic hydrolysis of Zn(OAc)(2) in the presence of oleic acid and then functionalized with…”
Get more information

Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope? by Ciccolini, Joseph, Gross, Eva, Dahan, Laetitia, Lacarelle, Bruno, Mercier, Cédric

“…Abstract 5-Fluorouracil (5-FU) is a mainstay for treating colorectal cancer, alone or more frequently as part of combination therapies. However, its…”
Get full text

Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit? by Mercier, Cédric, Ciccolini, Joseph

Get full text

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?—Potential therapeutic applications by Roché, Pauline, Venton, Geoffroy, Berda‐Haddad, Yaël, Fritz, Shirley, Ivanov, Vadim, Mercier, Cédric, Colle, Julien, Tichadou, Antoine, Fanciullino, Raphaëlle, Lepidi, Hubert, Costello, Régis, Farnault, Laure

Get full text

Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients by Venton, Geoffroy, Turcanu, Mihai, Colle, Julien, Thuny, Franck, Chebrek, Safia, Farnault, Laure, Mercier, Cédric, Ivanov, Vadim, Fanciullino, Raphaëlle, Suchon, Pierre, Jarrot, Pierre-André, Aissi, Karim, Roche, Pauline, Cautela, Jennifer, Arcani, Robin, Costello, Regis

“…Chronic myeloproliferative neoplasms (MPN) are recognized as a cause of pulmonary hypertension (pH). We ought to describe the prevalence and characteristics of…”
Get full text

Profiling Dihydropyrimidine Dehydrogenase Deficiency in Patients with Cancer Undergoing 5-Fluorouracil/Capecitabine Therapy by Mercier, Cédric, Ciccolini, Joseph

“…Fluoropyrimidine drugs such as 5-fluorouracil (5-FU) and capecitabine are a mainstay in the treatment of numerous solid tumors, including colorectal cancers,…”
Get full text

Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone by Arcani, Robin, Venton, Geoffroy, Colle, Julien, Suchon, Pierre, Ivanov, Vadim, Mercier, Cédric, Farnault, Laure, Roche, Pauline, Lafage, Marina, Brunet, Corinne, Azouza, Wakil, Pourroy, Bertrand, Fanciullino, Raphaëlle, Costello, Regis

“…Objectives Recently, phase III trials assessed a new combination of lenalidomide, bortezomib, and dexamethasone (RVD) in induction therapy in…”
Get full text

A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation by Labiad, Yasmine, Ventona, Geoffroy, Farnault, Laure, Baier, Céline, Colle, Julien, Mercier, Cédric, Ivanov, Vadim, Nicolino, Corinne, Loriod, Béatrice, Fernandez-Nunez, Nicolas, Torres, Magali, Mattei, Jean-Camille, Rihet, Pascal, Nguyen, Catherine, Costello, Régis

“…•A transcriptomic signature predicts infection in neutropenic patients.•The expression of 11 genes can be used routinely for sepsis prediction.•Early…”
Get full text

5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases by Cordier, Pierre-Yves, Nau, André, Ciccolini, Joseph, Oliver, Manuela, Mercier, Cédric, Lacarelle, Bruno, Peytel, Eric

“…Purpose 5-Fluorouracil (5-FU) is a mainstay for treating various solid tumours in adults, including digestive and head and neck cancers. 5-FU-related…”
Get full text

Pulmonary hypertension in patients with chronic myeloproliferative neoplasms by Chebrek, Safia, Aïssi, Karim, Francès, Yves, Mercier, Cédric, Farnault, Laure, Sébahoun, Gérard, Costello, Régis

Get full text

DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity by Yang, Chen Guang, Ciccolini, Joseph, Blesius, Aurore, Dahan, Laetitia, Bagarry-Liegey, Danielle, Brunet, Caroline, Varoquaux, Arthur, Frances, Nicolas, Marouani, Hafedh, Giovanni, Antoine, Ferri-Dessens, Rose-Marie, Chefrour, Mohamed, Favre, Roger, Duffaud, Florence, Seitz, Jean-François, Zanaret, Michel, Lacarelle, Bruno, Mercier, Cédric

“…Background Fluoropyrimidine drugs are widely used in head and neck cancer (HNC). DPD deficiency is a pharmacogenetics syndrome associated with severe/lethal…”
Get full text

Sudden death related to toxicity in a patient on capecitabine and irinotecan plus bevacizumab intake: pharmacogenetic implications by Dahan, Laetitia, Ciccolini, Joseph, Evrard, Alexandre, Mbatchi, Litaty, Tibbitts, Jack, Ries, Pauline, Norguet, Emmanuelle, Mercier, Cedric, Iliadis, Athanassios, Ouafik, L'Houcine, Lacarelle, Bruno, Seitz, Jean-Francois

Get full text

Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results by Mercier, Cédric, Evrard, Alexandre, Ciccolini, Joseph

Get full text